ARTICLE | Clinical News

HGTV43: Phase I

January 28, 2002 8:00 AM UTC

Follow-up data from a U.S. Phase I trial of HGTV43 showed that all 5 HIV patients treated had engineered cells still circulating. In addition, 1 patient had an increase in CD4 T cell count despite a h...